by Hillary Tsang | Mar 22, 2018 | NGLY1 |
In 2016, Perlara and Grace Science Foundation launched a PerlQuest for NGLY1 Deficiency (also known as NGLY1-CDDG). As a part of this collaboration, we have embarked on developing an NGLY1 worm screen. This post will detail the worm team’s latest progress toward...
by Feba Sam | Oct 29, 2016 | Perlara science |
High throughput screening (HTS) is essential in the process of finding a potential drug candidate, and automation is key for a good screen both in terms of robustness and efficiency. I kept hearing about the Echo since the day I joined Perlara, but it was only until a...
